Biolex Therapeutics to Present at the BioCentury and Thomson Financial "Future Leaders in the Biotech Industry" Conference

PITTSBORO, NC -- (MARKET WIRE) -- March 26, 2007 -- Biolex Therapeutics today announced that it will be presenting at the Future Leaders in the Biotech Industry conference hosted by BioCentury and Thomson Financial on Thursday, March 29, 2007 at the Millennium Broadway Hotel in New York City. Biolex management will provide an update regarding recent and upcoming milestones, including the Locteron™ Phase 2 program in hepatitis C, the advancement of BLX-155, and programs associated with the optimization of monoclonal antibodies.

Back to news